Literature DB >> 18201902

Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004.

Kwok Leung Ong1, Bernard M Y Cheung, Louisa Y F Wong, Nelson M S Wat, Kathryn C B Tan, Karen S L Lam.   

Abstract

PURPOSE: This study aimed to examine the trends in prevalence, treatment, and control of diagnosed diabetes in United States adults 20 years of age or older.
METHODS: Data from the National Health and Nutrition Examination Survey 1999-2004 were used. Glycemic, blood pressure, and total cholesterol target levels were defined as having glycosylated hemoglobin <7.0%, blood pressure <130/80 mm Hg, and total cholesterol <200 mg/dL, respectively.
RESULTS: The prevalence of diagnosed diabetes was 7.8% in 2003-2004 and increased significantly in people aged 40-59 years, women, non-Hispanic whites, and obese people in the period 1999-2004. Although there was no significant change in the pattern of antidiabetic treatment, the age-adjusted percentage of people with diagnosed diabetes achieving glycemic and blood pressure target levels increased from 35.8% to 57.1% (p = 0.002) and from 35.7% to 48.3% (p = 0.04), respectively. However, there were only insignificant increases in percentages of those persons achieving total cholesterol target level (from 48.8% to 50.4%) and those achieving all 3 target levels (from 7.5% to 13.2%).
CONCLUSIONS: In 1999-2004, the prevalence of diagnosed diabetes increased significantly in some subgroups of the population. However, the increases in percentages of people with diabetes achieving glycemic and blood pressure targets are encouraging, although there is room for improvement.

Entities:  

Mesh:

Year:  2008        PMID: 18201902     DOI: 10.1016/j.annepidem.2007.10.007

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  88 in total

1.  Low Plasma Hdl Cholesterol and Elevated C Reactive Protein further Increase Cardiovascular Disease Risk in Latinos with Type 2 Diabetes.

Authors:  Mariana C Calle; Sonia Vega-López; Sofia Segura-Pérez; Jeff S Volek; Rafael Pérez-Escamilla; Maria Luz Fernandez
Journal:  J Diabetes Metab       Date:  2010-11-10

2.  Race/ethnicity, social support, and associations with diabetes self-care and clinical outcomes in NHANES.

Authors:  Courtney A Rees; Andrew J Karter; Bessie A Young
Journal:  Diabetes Educ       Date:  2010-03-23       Impact factor: 2.140

3.  Health Care Disparities and Diabetes Care: Practical Considerations for Primary Care Providers.

Authors:  Richard O White; Bettina M Beech; Stephania Miller
Journal:  Clin Diabetes       Date:  2009-06

4.  Insulin-Treated Patients with Diabetes Mellitus Undergoing Emergency Abdominal Surgery Have Worse Outcomes than Patients Treated with Oral Agents.

Authors:  Tobias Haltmeier; Elizabeth Benjamin; Elizabeth Beale; Kenji Inaba; Demetrios Demetriades
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

Review 5.  Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences.

Authors:  Roberta Baetta; Alberto Corsini
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

6.  Self-reported diabetes in Hispanic subgroup, non-Hispanic black, and non-Hispanic white populations: National Health Interview Survey, 1997-2005.

Authors:  Luisa N Borrell; Natalie D Crawford; Florence J Dallo; Maria C Baquero
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

7.  Spending for diabetes drugs is increasing in the United States.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2008-07

8.  A dipeptidyl peptidase-4 inhibitor for adults with type 2 diabetes.

Authors: 
Journal:  P T       Date:  2010-02

9.  Long-Term Engagement with Health-Management Technology: a Dynamic Process in Diabetes.

Authors:  Predrag Klasnja; Logan Kendall; Wanda Pratt; Katherine Blondon
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

10.  Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline.

Authors:  Nilka Ríos Burrows; Yanfeng Li; Linda S Geiss
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.